Top Tweets for #ReSECT

20 days ago

#RESECT study investigates impact of observation and feedback on surgeon performance. Kevin Gallagher, MBChB, BMedSci, MSc, MRCS & @veerukasi join @UroDocAsh to present the RESECT trial, a cluster randomized study across 220 hospitals with over 15,000 TURBT cases testing audit and feedback interventions where the intervention improved documentation of tumor features and completeness of resection. #WatchNow on UroToday > https://t.co/IyVrbOqUZW @BURSTurology

0

7

4

1

1K

about 2 months ago

#RESECT study investigates impact of observation and feedback on surgeon performance. Kevin Gallagher, MBChB, BMedSci, MSc, MRCS & @veerukasi join @UroDocAsh to present the RESECT trial, a cluster randomized study across 220 hospitals with over 15,000 TURBT cases testing audit and feedback interventions where the intervention improved documentation of tumor features and completeness of resection. #WatchNow on UroToday > https://t.co/IyVrbOqUZW @BURSTurology

0

9

6

1

1K

Angie | ໒꒱ @quixoticCaptain

3 months ago

#RESECT study investigates impact of observation and feedback on surgeon performance. Kevin Gallagher, MBChB, BMedSci, MSc, MRCS & @veerukasi join @UroDocAsh to present the RESECT trial, a cluster randomized study across 220 hospitals with over 15,000 TURBT cases testing audit and feedback interventions where the intervention improved documentation of tumor features and completeness of resection. #WatchNow on UroToday > https://t.co/IyVrbOqUZW @BURSTurology

0

12

6

8

2K

3 months ago

How did Kazui not kill himself after that like genuinely I would be dead if that was me bro he’s like stronger than me man #resect

1

418

120

9

5K

Jethro Kwong @jethro_kwong

3 months ago

#RESECT study investigates impact of observation and feedback on surgeon performance. Kevin Gallagher, MBChB, BMedSci, MSc, MRCS & @veerukasi join @UroDocAsh to present the RESECT trial, a cluster randomized study across 220 hospitals with over 15,000 TURBT cases testing audit and feedback interventions where the intervention improved documentation of tumor features and completeness of resection. #WatchNow on UroToday > https://t.co/IyVrbOqUZW @BURSTurology

1

14

5

4

2K

4 months ago

Performance of these tools remain modest, since recurrence is a challenging outcome to predict. +Factors that impact recurrence like resection technique (En-bloc resection, EB-StaR trial by @jteoh_hk) and periop practices (#RESECT study) are not incorporated in these tools

0

6

1

0

565

Prof Veeru Kasi @veerukasi

4 months ago

Interested in improving bladder cancer outcomes? Check out our video series on the importance of #RESECT: monitoring your own outcomes can improve how well TURBT surgery is done: cluster randomised trial now published in @EUplatinum #EAU26 https://t.co/AKc5qMqjhd @BURSTurology

4 months ago

1/6 💬 What is a TURBT? It's the most common operation in #bladdercancer - used to diagnose, stage, and treat the disease. But what does it actually involve? Our experts explain 👇 Follow @BURSTurology for the full series on the #RESECT study, the largest #TURBT study ever conducted 📹 In this short: @veerukasi @luca_orecchia @JGomezRivas @UroDocAsh @MariaJRibal

1

10

6

2

3K

0

10

6

2

2K

4 months ago

6/6 Where do we go from here? @veerukasi explains how #RESECT’s data can shape the future of TURBT training - and why national audits may be the key to reducing #bladdercancer recurrence at scale. This is what @BURSTurology was built for. The biggest project in our 10-year history - and we're just getting started. 📄 Read the paper, @EUplatinum: https://t.co/OJzewK7g1l 🔔 Follow us for what's next 👀 Will we see you at #EAU26 on Sat 14, 1-3pm at Connaught 1 in London?

1

4

5

0

434

4 months ago

5/6 💡 What if comparing your surgical performance against your peers could reduce cancer recurrence? That's what #RESECT set out to test - across 220+ hospitals worldwide. The results challenge how we think about quality improvement in #surgery. 📄 Full paper in @EUplatinum: https://t.co/OJzewK7g1l Follow for more practice-changing studies 👉 @BURSTurology 📹 In this short: @kmj_gallagher @JGomezRivas

1

7

0

439

4 months ago

4/6 🌍 220+ hospitals. 45+ countries. 15,000+ patients. 1,300+ collaborators. #RESECT is the largest study of #TURBT surgery ever conducted. The question: can giving surgeons private feedback on their quality improve how they operate... and ultimately reduce #bladder #cancer #recurrence? 📄 Read what we found: https://t.co/OJzewK7g1l 📹 In this short: @kmj_gallagher @luca_orecchia @JGomezRivas @jteoh_hk

1

6

5

0

418

4 months ago

2/6 ⚠️ Same operation. Different outcomes. Why? #TURBT outcomes can vary depending on technique, experience, and judgement... and that variation directly affects whether a patient's #cancer comes BACK! That's why we started #RESECT: to measure it, understand it, and fix it. 📄 Full paper in @EUplatinum: https://t.co/OJzewK7g1l 📹 In this short: @veerukasi @luca_orecchia @UroDocAsh @kmj_gallagher & Miss Cresswell

1

5

4

0

361

Sandesh Acharya 🤫 @Ramghalee

4 months ago

1/6 💬 What is a TURBT? It's the most common operation in #bladdercancer - used to diagnose, stage, and treat the disease. But what does it actually involve? Our experts explain 👇 Follow @BURSTurology for the full series on the #RESECT study, the largest #TURBT study ever conducted 📹 In this short: @veerukasi @luca_orecchia @JGomezRivas @UroDocAsh @MariaJRibal

1

10

6

2

3K

4 months ago

आशा जगाईराख्नु छ । #Resect

0

9

1

0

284

Prof Veeru Kasi @veerukasi

4 months ago

What a great honour to have representation from 1/4 of the world (48 countries) in our @BURSTurology #RESECT study 💪🏾 . 🙏🏾 for taking part. Delighted to lead this work which will improve bladder cancer care. #EAU26 @Uroweb Full paper here: https://t.co/CgvGOvmsk5

Prof Veeru Kasi @veerukasi

4 months ago

🤔 What if just WATCHING surgeons made them better? In #RESECT, #bladdercancer recurrence DROPPED in the control arm alone. No new drug. No new device. JUST observation. @veerukasi & @kmj_gallagher break down the results with @EAU_Uroonco👇 📽️ https://t.co/f2XVzru5cm 📄 Full paper: https://t.co/OJzewK7g1l 45+ countries. 220+ hospitals. 1300+ collaborators. 15,000+ patients. ‼️The case for national and international TURBT audits has NEVER been stronger. #UroSoMe

BURSTurology's tweet photo. 🤔 What if just WATCHING surgeons made them better?

In #RESECT, #bladdercancer recurrence DROPPED in the control arm alone.

No new drug. No new device. JUST observation.

@veerukasi & @kmj_gallagher break down the results with @EAU_Uroonco👇

📽️ https://t.co/f2XVzru5cm

📄 Full paper: https://t.co/OJzewK7g1l

45+ countries. 220+ hospitals. 1300+ collaborators. 15,000+ patients.

‼️The case for national and international TURBT audits has NEVER been stronger.

#UroSoMe

0

11

4

1

2K

0

14

5

1

1K

4 months ago

Look forward to 👀 you there on Sat 13.00 Connaught 1 @ #EAU26. Great opportunity to collaborate & get involved with our global projects. See results from #WASHOUT on emergency haematuria & reflect on successes #RESECT https://t.co/CgvGOvmsk5 @Uroweb @BAUSurology @BURSTurology

4 months ago

🚨 FOUR DAYS to go until BURST at #EAU26! | The Future of International Research 📅 Sat 14 Mar | 🕐 13:00-15:00 | 📍 Connaught 1 ✅ #WASHOUT results & next steps 🌍 Global collaborator perspectives on international research 🚀 Open discussion: how to get involved with BURST We can’t wait to see you in London! #UroSoMe

BURSTurology's tweet photo. 🚨 FOUR DAYS to go until BURST at #EAU26! | The Future of International Research

📅 Sat 14 Mar | 🕐 13:00-15:00 | 📍 Connaught 1

✅ #WASHOUT results & next steps
🌍 Global collaborator perspectives on international research
🚀 Open discussion: how to get involved with BURST

We can’t wait to see you in London! #UroSoMe

0

8

0

2K

0

6

4

1

720

4 months ago

🤔 What if just WATCHING surgeons made them better? In #RESECT, #bladdercancer recurrence DROPPED in the control arm alone. No new drug. No new device. JUST observation. @veerukasi & @kmj_gallagher break down the results with @EAU_Uroonco👇 📽️ https://t.co/f2XVzru5cm 📄 Full paper: https://t.co/OJzewK7g1l 45+ countries. 220+ hospitals. 1300+ collaborators. 15,000+ patients. ‼️The case for national and international TURBT audits has NEVER been stronger. #UroSoMe

0

11

4

1

2K

Daben Dawam @DabenDawam

4 months ago

Landmark Study on best practices of TURBT Surgery #RESECT https://t.co/JTDKqM34mw

0

2

0

55

4 months ago

#RESECT study investigates impact of observation and feedback on surgeon performance. Kevin Gallagher, MBChB, BMedSci, MSc, MRCS & @veerukasi join @UroDocAsh to present the RESECT trial, a cluster randomized study across 220 hospitals with over 15,000 TURBT cases testing audit and feedback interventions where the intervention improved documentation of tumor features and completeness of resection. #WatchNow on UroToday > https://t.co/IyVrbOqUZW @BURSTurology

2

12

8

2

2K